PluriSln 1 – 25 mg

Brand:
Cayman
CAS:
91396-88-2
Storage:
-20
UN-No:
Non-Hazardous - /

PluriSln 1 is an N-acyl phenylhydrazine derivative that inhibits stearoyl-CoA desaturase, a key enzyme for lipid metabolism that is expressed in human pluripotent stem cells (hPSCs).{26485} PluriSln 1 can selectively induce ER stress, attenuate protein synthesis, and induce apoptosis in hPSCs (EC50 = 2 µM) while sparing progenitor and differentiated cells.{26485} Because PluriSln 1 can selectively eliminate undifferentiated hPSCs, it was developed as a strategy to prevent tumorigenic risk from residual undifferentiated cells used during stem cell therapy. In immunocompromised mice, PluriSln 1 has been shown to effectively prevent teratoma formation from undifferentiated hPSCs.{26485}  

 

SKU: - Category:

Description

An inhibitor of stearoyl-CoA desaturase that selectively eliminates hPSCs (EC50 = 2 µM) while sparing progenitor and differentiated cells; developed as a strategy to prevent tumorigenic risk from residual undifferentiated cells used during stem cell therapy


Formal name: 2-phenylhydrazide-4-pyridinecarboxylic acid

Synonyms:  N’-phenyl-hydrazine-Isonicotinic acid|NSC 14613

Molecular weight: 213.2

CAS: 91396-88-2

Purity: ≥95%

Formulation: A crystalline solid


Product Type|Biochemicals|Small Molecule Inhibitors|Fatty Acid Metabolism||Research Area|Cancer||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking||Research Area|Cell Biology|Stem Cell Research|Differentiation